BioArctic
306.80 SEK
-3.52 %
Less than 1K followers
BIOA B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for BioArctic
P/E
Median 2019-2025
EV/S
Median 2019-2024
EV/EBIT
Median 2019-2024
Dividend yield
Median 2019-2025
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 94.90 | 95.40 | 119.20 | 272.00 | 267.80 | 199.50 | 310.80 |
| Shares | 88.1 | 88.1 | 88.1 | 88.1 | 88.3 | 88.4 | 88.6 |
| Market cap | 8,356.8 | 8,400.8 | 10,496.8 | 23,971.8 | 23,650.8 | 17,633.6 | 27,548.5 |
| Enterprise value | 7,271.4 | 7,421.7 | 9,664.2 | 23,139.3 | 23,044.2 | 17,174.9 | - |
| EV/S | 25.8 | 119.0 | 417.5 | 101.4 | 37.4 | 66.7 | - |
| EV/EBITDA | 59.7 | neg. | neg. | neg. | 85.0 | neg. | - |
| EV/EBIT | 64.6 | neg. | neg. | neg. | 91.2 | neg. | - |
| P/E | 94.5 | neg. | neg. | neg. | 103.0 | neg. | 26.9 |
| P/B | 8.58 | 9.26 | 13.31 | 30.49 | 22.60 | 19.70 | 14.00 |
| P/S | 29.7 | 134.7 | 453.5 | 105.0 | 38.4 | 68.5 | 13.8 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.6 % |
| Equity ratio | 82.4 % | 86.4 % | 87.9 % | 91.6 % | 88.2 % | 80.5 % | 76.4 % |
| Gearing ratio | 2.8 % | 2.3 % | 2.0 % | 2.0 % | 0.5 % | 6.1 % | 2.2 % |